Viewing Study NCT01923233


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-01 @ 1:10 AM
Study NCT ID: NCT01923233
Status: WITHDRAWN
Last Update Posted: 2020-01-22
First Post: 2013-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Sponsor: Mirror Biologics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-11
Start Date Type: ACTUAL
Primary Completion Date: 2015-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2015-06
Completion Date Type: ACTUAL
First Submit Date: 2013-08-12
First Submit QC Date: None
Study First Post Date: 2013-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-01-17
Last Update Post Date: 2020-01-22
Last Update Post Date Type: ACTUAL